Replies to post #602 on Nascent Biotech Inc. (NBIO)

[Allnewsisgoodnews]

Pritumumab

Well, looks like some new buyers have joined in my friend!

We expect that data from the cell line testing will come in sometime soon.

"The Company has initiated tests to assess the possibility that its lead asset, the monoclonal antibody Pritumumab (PTB) could be used as a potential therapy against the novel coronavirus, or SARS-CoV-2"

https://www.globenewswire.com/news-release/2020/04/22/2019823/0/en/Nascent-Biotech-Provides-Shareholder-Update-on-COVID-19-Therapy-and-Brain-Cancer-Trials.html

[subslover]

In for another 10k shares.